Bioadaptives PR 09/24/19

BIOADAPTIVES,INCannounces TizHemp,anewHemp-productDivision

& appointment of new CFO

 

LasVegasNevada,September24,2019,(GLOBENEWSWIRE)--viaNEWMEDIAWIRE--Bioadaptives,Inc.(OTCBB:BDPT)announcedtheCompany’sformationofTisHemp,anewoperatingdivisiontoconcentrateeffortsonwellness-relatedhemp-basedproducts,andtheappointmentofMr.RonLambrechtastheCompany’snewChiefFinancialOfficer,reportingtotheCEO,President,andBoard,effective1October,2019.

Dr.Jacobs,DirectorandCEOsaid,“WeareverypleasedtobeorganizingourCompanytobecomeasignificantparticipantintherelatively-newandexplosivehempproductsindustry.OurnewHempProductsDivisionwillfocusitsattentiononthedevelopment,testing,production,anddistributionofhemp-basedhealthandwellnessproductsforhumanandanimal application.Wefully support the perceived health benefits of hemp,and,as such,believe this expansiontobe anaturalcomplementtoourCompany’scoreproductplans,andakeycontributortofuturebottom-lineperformanceoftheCompany.Initialproductspromotinghealthandwellness,includingtopicals,nutritionalpowderandtea,willbe availableforsalebeginningOctoberofthisyear.”

Mr.RobertEllis,Presidentstated,“Wearepleasedtoannouncetheadditionof Mr.RonLambrechtasournewChiefFinancialOfficer.Mr.LambrechtisaWesternMontanaCPA,andavery successful businessman.We look forwardtohis participationinthefinancialmanagementoftheCompanyasweexpand.”Forthepast25yearsMr.Lambrechthasoperatedafinancialservicesbusinessinadditiontofacilitatinganumberoftechnologyacquisitionsandjointventuretransactions.

About BioAdaptives,Inc.

BioAdaptives,Inc.isafully-reporting,publiccompanytradingontheOTCBulletinBoardunderthe symbolBDPT.The companyis engagedinresearch, development, andmarketing of science-based nutraceuticalproducts forhuman and animalconsumption.

SAFE HARBORACT

Forward-LookingStatements:Thisreleasecontainsstatementsthatconstituteforward-lookingstatementswithinthemeaningof Section27AoftheSecurities Act of 1933,as amended,and

Section21EoftheSecuritiesExchangeActof1934,asamended.Thesestatementsappearinanumberofplacesinthis releaseandincludeallstatements thatarenotstatementsofhistoricalfact regarding the intent, belief orcurrentexpectations of BioAdaptives, Inc.andits directors oritsofficerswithrespectto,amongotherthings:(i)financingplans;(ii)trendsaffectingitsfinancialconditionorresultsofoperations;(iii)growthstrategyandoperatingstrategy.Thewords"may,""would,""will,""expect,""estimate,""can,""believe,""potential"andsimilarexpressionsandvariationsthereofareintendedtoidentify forward-lookingstatements. Investorsarecautionedthatanysuchforward-lookingstatementsarenotguaranteesoffutureperformanceandinvolverisksanduncertainties,manyofwhicharebeyondBioAdaptives,Inc.'sabilitytocontrol,andactual resultsmay differmaterially from those projected inthe forward-looking statementsas aresultofvariousfactors.MoreinformationaboutthepotentialfactorsthatcouldaffectthebusinessandfinancialresultsisandwillbeincludedinBioAdaptives,Inc.'sfilingswiththeSecuritiesand Exchange Commission.

 

 

 

Ticker: OTCBB:BDPT/OTC:BDPT/OP: BDPT

 

 

###

MediaContact:RobertW.Ellis

President,BioAdaptives,Inc702-659-8829EXT703

Email:rwe@bioadaptives.com

 

 

SOURCE:BioAdaptives,Inc.